NCT03684018RecruitingPhase 4
Two Dose Levels of Privigen in Pediatric CIDP
Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP
Source: ClinicalTrials.gov · Last updated 1 Jun 2026
Brief summary (registry, in English)
A randomized, open-label, prospective, multicenter study designed to investigate 2 dose levels in pediatric subjects 2 to ≤ 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 24 Sept 2018
- Start date
- 28 Feb 2019
- Primary completion date
- 20 Dec 2029
- Lead sponsor
- CSL Behring
- NCT number
- NCT03684018
- EudraCT number
- 2018-003430-33
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 30
- From 28 Feb 2019 to the primary completion date, 20 Dec 2029
- 9 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- -History or family history of inherited neuropathy
- -History of thrombotic episode
- -Known or suspected hypersensitivity to Privigen
- -Known allergic or other severe reactions to blood products
Other
- \- Absence of CIDP symptoms
- -Diagnosed developmental delay or regression
- -Female subject of childbearing potential either not using or not willing to use a medically reliable method of contraception or not sexually abstinent during the study
- -Pregnant or breastfeeding mother"
Who the study is looking for
- \- Male or female subjects 2 to ≤ 17 years of age with confirmed or possible CIDP.
Age in the registry: 2 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Akron Children's Hospital Coordinator of this site? Confirm its status | Akron | United States | Withdrawn |
| Neurology Rare Disease Center Coordinator of this site? Confirm its status | Flower Mound | United States | Recruiting |
| University of Iowa Hospitals and Clinics Coordinator of this site? Confirm its status | Iowa City | United States | Withdrawn |
| Children's Hospital of Los Angeles Coordinator of this site? Confirm its status | Los Angeles | United States | Withdrawn |
| Le Bonheur Children's Hospital Coordinator of this site? Confirm its status | Memphis | United States | Withdrawn |
| Children's Specialty Group Coordinator of this site? Confirm its status | Norfolk | United States | Completed |
| Children's Hospital of Philadelphia Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
| Phoenix Children s Hospital Coordinator of this site? Confirm its status | Phoenix | United States | Completed |
| Seattle Children's Hospital Coordinator of this site? Confirm its status | Seattle | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.